[1]
Zajkowska J.M., Pancewicz S.A., Grygorczuk S., et al.: Neuroborelioza–
wybrane aspekty patogenezy, diagnostyki i leczenia. Pol. Merk. Lek.
2008; 24: 453–457.
[1]
Zajkowska J.M., Pancewicz S.A., Grygorczuk S., et al.: Neuroborelioza–
wybrane aspekty patogenezy, diagnostyki i leczenia. Pol. Merk. Lek.
2008; 24: 453–457.
[2]
Nau R., Christen H.J., Eiffert H.: Lyme Disease- Current State of Knowledge.
Dtsch Arztebl Int. 2009; 106: 72–82.
[2]
Nau R., Christen H.J., Eiffert H.: Lyme Disease- Current State of Knowledge.
Dtsch Arztebl Int. 2009; 106: 72–82.
[3]
Zajkowska J.M., Hermanowska-Szpakowicz T., Grygorczuk S., et al.:
Neuroborelioza. Pol Przeg Neurol 2006; 2: 13–21.
[3]
Zajkowska J.M., Hermanowska-Szpakowicz T., Grygorczuk S., et al.:
Neuroborelioza. Pol Przeg Neurol 2006; 2: 13–21.
[4]
Żarowski M., Młodzikowska-Albrecht J., Steinborn B.: Symptomatologia
boreliozy u dzieci i młodzieży leczonych w Klinice Neurologii Wieku
Rozwojowego AM w Poznaniu. Neurol Dziec 2006; 15: 21–26.
[4]
Żarowski M., Młodzikowska-Albrecht J., Steinborn B.: Symptomatologia
boreliozy u dzieci i młodzieży leczonych w Klinice Neurologii Wieku
Rozwojowego AM w Poznaniu. Neurol Dziec 2006; 15: 21–26.
[5]
Zajkowska J., Hermanowska-Szpakowicz T.: Nowe aspekty
patogenetyczne boreliozy z Lyme. Przegl. Epidemiol 2002; 56: 57–67.
[5]
Zajkowska J., Hermanowska-Szpakowicz T.: Nowe aspekty
patogenetyczne boreliozy z Lyme. Przegl. Epidemiol 2002; 56: 57–67.
[6]
Czupryna P., Kusmierczyk J., Zajkowska J.M., et al.: Clinical forms of
neuroborreliosis among hospitalized patients in the years 200–2005. Pol
Merkur Lekarski 2007; 23: 103–106.
[6]
Czupryna P., Kusmierczyk J., Zajkowska J.M., et al.: Clinical forms of
neuroborreliosis among hospitalized patients in the years 200–2005. Pol
Merkur Lekarski 2007; 23: 103–106.
[7]
Mygland A., Ljostad U., Fingerle V., et al.: EFNS guidelines on the diagnosis
and management of European Lyme neuroborreliosis. Eur J Neurol 2010;
17: 8–16.
[7]
Mygland A., Ljostad U., Fingerle V., et al.: EFNS guidelines on the diagnosis
and management of European Lyme neuroborreliosis. Eur J Neurol 2010;
17: 8–16.
[8]
Flisiak R., Pancewicz S.: Diagnostyka i leczenie Boreliozy z Lyme
rekomendacje Polskiego Towarzystwa Epiedmiologów i Lekarzy Chorób
Zakaźnych. Przegl Epidemiol 2008; 62: 193–199.
[8]
Flisiak R., Pancewicz S.: Diagnostyka i leczenie Boreliozy z Lyme
rekomendacje Polskiego Towarzystwa Epiedmiologów i Lekarzy Chorób
Zakaźnych. Przegl Epidemiol 2008; 62: 193–199.
[9]
Bremell D., Hagberg L.: Clinical characteristics and cerebrospinal fluid
parameters in patients with peripheral facial palsy caused by Lyme
neuroborreliosis compared with facial palsy of unknown origin (Bell’s
palsy). BMC Infect Dis 2011; 11: 215.
[9]
Bremell D., Hagberg L.: Clinical characteristics and cerebrospinal fluid
parameters in patients with peripheral facial palsy caused by Lyme
neuroborreliosis compared with facial palsy of unknown origin (Bell’s
palsy). BMC Infect Dis 2011; 11: 215.
[10]
Peltomaa M., Pyykkö I., Seppälä I.: Lyme borreliosis and facial paralysis-a
prospective analysis of risk factors and outcome. Am J Otolaryngol
2002; 23: 125–132.
[10]
Peltomaa M., Pyykkö I., Seppälä I.: Lyme borreliosis and facial paralysis-a
prospective analysis of risk factors and outcome. Am J Otolaryngol
2002; 23: 125–132.
[11]
Jenke AC., Stoek LM, Zilbauer M., et al.: Facial palsy: Etiology, outcome
and management in children. Eur J Paediatr Neurol 2011; 15: 209–213.
[11]
Jenke AC., Stoek LM, Zilbauer M., et al.: Facial palsy: Etiology, outcome
and management in children. Eur J Paediatr Neurol 2011; 15: 209–213.
[12]
Øymar K., Tveitnes D.: Clinical Chracteristics of childchood Lyme
neuroborreliosis in an endemic area of northern Europe. Scand J Infect
Dis 2009; 41: 88–94.
[12]
Øymar K., Tveitnes D.: Clinical Chracteristics of childchood Lyme
neuroborreliosis in an endemic area of northern Europe. Scand J Infect
Dis 2009; 41: 88–94.
[13]
Brunner J., Moschovakis G., Prelog M., et al.: Lyme neuroborreliosis:
aetiology and diagnosis of facial palsy in children from Tyrol. Klin Pediatr
2010; 222: 302–307.
[13]
Brunner J., Moschovakis G., Prelog M., et al.: Lyme neuroborreliosis:
aetiology and diagnosis of facial palsy in children from Tyrol. Klin Pediatr
2010; 222: 302–307.
[14]
Nigrovic L.E., Thompson A.D., Fine A.M., et al.: Clinical predictors
of Lyme disease among children with a peripheral facial palsy at an
emergency department in a Lyme disease-endemic area. Pediatrics
2008; 122: 1080–1085.
[14]
Nigrovic L.E., Thompson A.D., Fine A.M., et al.: Clinical predictors
of Lyme disease among children with a peripheral facial palsy at an
emergency department in a Lyme disease-endemic area. Pediatrics
2008; 122: 1080–1085.
[15]
López-Alberola R.F.: Neuroborreliosis in pediatric population: a review.
Rev Neurol 2006; 42: 91–96.
[15]
López-Alberola R.F.: Neuroborreliosis in pediatric population: a review.
Rev Neurol 2006; 42: 91–96.
[16]
Garro A.C, Rutman M., Simonsen K., et al.: Prospective Validation of
a Clinical Prediction Model for Lyme Meningitis in Children. Pediatrics
2009; 123: 829–834.
[16]
Garro A.C, Rutman M., Simonsen K., et al.: Prospective Validation of
a Clinical Prediction Model for Lyme Meningitis in Children. Pediatrics
2009; 123: 829–834.
[17]
Müllegger R.R., Millner M.M., Stanek G. et al: Penicillin G sodium
and ceftriaxone in the treatment of neuroborreliosis in children – A
prospecive study. Infection 1991; 19: 279–283.
[17]
Müllegger R.R., Millner M.M., Stanek G. et al: Penicillin G sodium
and ceftriaxone in the treatment of neuroborreliosis in children – A
prospecive study. Infection 1991; 19: 279–283.
[18]
Vukelic D., Bozinovic D., Morovic M., et al.: Oposclonus-myoclonus
syndrome in a child with neuroborreliosis. J Infect 2000; 40: 189–191.
[18]
Vukelic D., Bozinovic D., Morovic M., et al.: Oposclonus-myoclonus
syndrome in a child with neuroborreliosis. J Infect 2000; 40: 189–191.
[19]
Ylitalo V., Hagberg BA.: Progressive ataxia in Swedish children:
re-evaluation study. Acta Neurol Scand 1994; 89: 299–302.
[19]
Ylitalo V., Hagberg BA.: Progressive ataxia in Swedish children:
re-evaluation study. Acta Neurol Scand 1994; 89: 299–302.
[20]
Wilke M., Eiffert H., Christen H.J., et al.: Primarily chronic and
cerebrovascular course of Lyme neuroborreliosis: case reports and
literature overview. Arch Dis Child 2000; 83: 67–71.
[20]
Wilke M., Eiffert H., Christen H.J., et al.: Primarily chronic and
cerebrovascular course of Lyme neuroborreliosis: case reports and
literature overview. Arch Dis Child 2000; 83: 67–71.
[21]
Broekhuijsen-van Henten D.M, Braun K.P.: Clinical presentation of
childhood neuroborreliosis; neurological examination may be normal.
Arch Dis Child 2010; 95: 910–914.
[21]
Broekhuijsen-van Henten D.M, Braun K.P.: Clinical presentation of
childhood neuroborreliosis; neurological examination may be normal.
Arch Dis Child 2010; 95: 910–914.
[22]
Tveitnes D., Øymar K., Natas O.: Laboratory data in children with
Lyme neuroborreliosis, relation to clinical presentation and duration of
symptoms. Scand J Infect Dis 2009; 41: 355–362.
[22]
Tveitnes D., Øymar K., Natas O.: Laboratory data in children with
Lyme neuroborreliosis, relation to clinical presentation and duration of
symptoms. Scand J Infect Dis 2009; 41: 355–362.
[23]
Bennet R, LindgrenV., Zweygberg Wirgart B.: Borrelia antibodies in
children evaluated for Lyme neuroborreliosis. Infection 2008; 36: 463–
466.
[23]
Bennet R, LindgrenV., Zweygberg Wirgart B.: Borrelia antibodies in
children evaluated for Lyme neuroborreliosis. Infection 2008; 36: 463–
466.
[24]
O’Connell S.: Lyme borreliosis: current issus in diagnosis and
management. Curr Opin Infect Dis 2010; 23: 231–235.
[24]
O’Connell S.: Lyme borreliosis: current issus in diagnosis and
management. Curr Opin Infect Dis 2010; 23: 231–235.
[25]
Baumann M., Brinbacher R., Koch J., et al.: Uncomon manifestation of
neuroboreliosis in children. Eur J Paediatr Neurol 2010; 14: 274–277.
[25]
Baumann M., Brinbacher R., Koch J., et al.: Uncomon manifestation of
neuroboreliosis in children. Eur J Paediatr Neurol 2010; 14: 274–277.
Scholar Google
PubMed